Eitaro Fujii
Overview
Explore the profile of Eitaro Fujii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kagawa Y, Takafuji M, Fujita S, Kokawa T, Fukuma T, Ishida M, et al.
Int J Cardiovasc Imaging
. 2025 Jan;
41(3):419-426.
PMID: 39883382
Myocardial extracellular volume fraction (ECV) measured via MRI serves as a quantitative indicator of myocardial fibrosis. However, accurate measurement of ECV using MRI in the presence of AF is challenging....
2.
Takafuji M, Kitagawa K, Nakamura S, Kokawa T, Kagawa Y, Fujita S, et al.
Physiol Rep
. 2021 Nov;
9(22):e15123.
PMID: 34806340
Background: Atrial fibrillation (AF) patients without coronary artery stenosis often show clinical evidence of ischemia. However myocardial perfusion in AF patients has been poorly studied. The purposes of this study...
3.
Kato N, Muraga K, Hirata Y, Shindo A, Matsuura K, Ii Y, et al.
Sci Rep
. 2021 Sep;
11(1):18995.
PMID: 34556757
Catheter ablation is an important non-pharmacological intervention for atrial fibrillation (AF), but its effect on the incidence of asymptomatic cerebral emboli and long-term effects on cognitive function remain unknown. We...
4.
Kagawa Y, Fujii E, Fujita S, Ito M
Heart Vessels
. 2019 Jul;
35(2):239-245.
PMID: 31346694
The success rate of catheter ablation of persistent atrial fibrillation (AF) is not satisfactory, for reasons that are unclear. The purpose of this study was to examine the relationship between...
5.
Kishi T, Fujii E
Hypertens Res
. 2019 Apr;
42(4):496-503.
PMID: 30948819
Although beta blockers have been used as initial therapy for ischemic heart diseases and heart failure, the beneficial effects of beta blockers are controversial compared with other antihypertensive agents as...
6.
Yamamoto M, Okajima K, Shimane A, Ozawa T, Morishima I, Asai T, et al.
Int Heart J
. 2019 Feb;
60(2):318-326.
PMID: 30745538
Implantable cardioverter-defibrillators (ICDs) improve survival in patients who are at risk of sudden death. However, inappropriate therapy is commonly given to ICD recipients, and this situation may be associated with...
7.
Okamoto R, Taniguchi M, Onishi Y, Kumagai N, Uraki J, Fujimoto N, et al.
Hypertens Res
. 2018 Nov;
42(1):40-51.
PMID: 30401909
It remains unknown which surrogate markers can predict diagnostic test results for primary hyperaldosteronism (PA). The Secondary Hypertension Registry Investigation in Mie Prefecture (SHRIMP) study has sequentially and prospectively recruited...
8.
Fujii E, Fujita S, Kagawa Y, Ito M
J Arrhythm
. 2018 Sep;
34(4):462-464.
PMID: 30167020
A 64-year-old man with an atrial septal defect was referred for HotBalloon ablation of symptomatic drug-resistant paroxysmal atrial fibrillation. Pulmonary vein (PV) isolation was achieved using a SATAKE HotBalloon ablation...
9.
Fujita S, Fujii E, Kagawa Y, Inoue K, Yamada T, Ito M
Heart Vessels
. 2018 May;
33(11):1373-1380.
PMID: 29736557
It is important to visually confirm radiofrequency ablation lesions during atrial fibrillation (AF) ablation for procedural efficiency, which requires the integration of a three-dimensional (3D) left atrial image reconstructed from...
10.
Omori T, Okamoto R, Fujimoto H, Masuda J, Kobayashi T, Fujii E, et al.
Circ J
. 2018 Mar;
82(10):2678-2679.
PMID: 29540629
No abstract available.